Min Shi

2.0k total citations
99 papers, 920 citations indexed

About

Min Shi is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Min Shi has authored 99 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 42 papers in Pathology and Forensic Medicine and 29 papers in Hematology. Recurrent topics in Min Shi's work include Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (31 papers) and Acute Myeloid Leukemia Research (16 papers). Min Shi is often cited by papers focused on Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (31 papers) and Acute Myeloid Leukemia Research (16 papers). Min Shi collaborates with scholars based in United States, China and United Kingdom. Min Shi's co-authors include Dragan Jevremović, Horatiu Olteanu, Pedro Horna, Gregory E. Otteson, David S. Viswanatha, Rong He, Andrew L. Feldman, Margaret A. Shipp, Geraldine S. Pinkus and Heather H. Sun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Min Shi

86 papers receiving 911 citations

Peers

Countries citing papers authored by Min Shi

Since Specialization

Citations

This map shows the geographic impact of Min Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Shi more than expected).

Fields of papers citing papers by Min Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Shi. The network helps show where Min Shi may publish in the future.

Co-authorship network of co-authors of Min Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Min Shi. A scholar is included among the top collaborators of Min Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Shi. Min Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial Intelligence‐Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 Trial 2025 ·MedComm ·(unknown), Wenjun Qiu, (unknown), Qiyun Ou, (unknown), (unknown), (unknown), Jiani Wu, (unknown), Wenchao Gu, Peng Luo, (unknown), Jianping Bin, Yulin Liao, Min Shi, (unknown), Huiying Sun, Yunfang Yu, (unknown), Dongqiang Zeng	0
2	Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia 2025 ·Cancers ·(unknown), Gregory E. Otteson, Michael Timm, (unknown), Min Shi, Pedro Horna, Dragan Jevremović, Kaaren K. Reichard, Horatiu Olteanu	0
3	Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry 2025 ·Cancers ·Jansen N. Seheult, Gregory E. Otteson, (unknown), Michael Timm, (unknown), Dragan Jevremović, Pedro Horna, Horatiu Olteanu, Min Shi	2
4	A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry 2025 ·Cytometry Part B Clinical Cytometry ·Jean Oak, (unknown), (unknown), Pedro Horna, Jonathan R. Fromm, Lianqun Qiu, Andrea Illingworth, (unknown), Wolfgang Kern, Ahmad Al‐Attar, Min Shi	0
5	1284 Clinicopathologic Findings in Anaplastic Large Cell Lymphoma Arising in the Setting of Immunosuppression 2025 ·Laboratory Investigation ·(unknown), (unknown), Stephen M. Ansell, Jennifer Chapman, Laurence de Leval, David L. Jaye, Min Shi, Andrew L. Feldman	0
6	Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features 2024 ·Journal of Investigative Dermatology ·Jansen N. Seheult, (unknown), Dragan Jevremović, Min Shi, Horatiu Olteanu, Pedro Horna	3
7	Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry 2024 ·Blood Cancer Journal ·Pedro Horna, (unknown), Mathieu Ferrari, (unknown), (unknown), (unknown), (unknown), Gregory E. Otteson, Jansen N. Seheult, Janosch Ortmann, Min Shi, Paul Maciocia, (unknown), Martin Pulé, Horatiu Olteanu	13
8	Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines 2024 ·Cytometry Part B Clinical Cytometry ·Sara A. Monaghan, Steven Eck, Silvia T. Bunting, (unknown), Robert J. Durso, (unknown), Amanda Hays, Andrea Illingworth, (unknown), (unknown), Megan McCausland, Thomas W. McCloskey, (unknown), Min Shi, Paul K. Wallace, Virginia Litwin, Wolfgang Kern, George Deeb, (unknown), Horatiu Olteanu	3
9	Maximal diameters and mean computed tomography (CT) value of synchronous multiple pure ground-glass opacities in lung adenocarcinoma are smaller 2024 ·Clinical Radiology ·(unknown), Lingzhou Zhao, Wei Zhao, Min Shi, Xiaoou Li, Zonghui Liang	1
10	Epigenetic Modification-Associated Molecular Classification of Gastric Cancer 2023 ·Laboratory Investigation ·(unknown), Jinfeng Zhu, Dongqiang Zeng, (unknown), (unknown), Yu Zeng, Ling Wang, Jianping Bin, Yulin Liao, Min Shi, Wangjun Liao	0
11	Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study 2023 ·Journal of Medical Genetics ·Chenghai Zhang, (unknown), (unknown), Min Shi, (unknown), (unknown), Bowen Zhu, Hou‐Quan Tao, Tonghui Ma, Tieying Hou	5
12	A study of frontline therapy in adults >80 years with chronic lymphocytic leukemia (CLL). 2023 ·Journal of Clinical Oncology ·Mazie Tsang, Paul J. Hampel, Kari G. Rabe, Wei Ding, José F. Leis, Saad S. Kenderian, Yucai Wang, Eli Muchtar, Amber B. Koehler, Curtis A. Hanson, Min Shi, Susan L. Slager, Neil E. Kay, Sameer A. Parikh	0
13	Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature 2022 ·Modern Pathology ·(unknown), Yuan Ji, Jun Wang, Qi Shen, Xueyan Chen, (unknown), Craig W. Zuppan, Chung-Che Chang, Wei Cui, Dong Chen, Min Shi, (unknown), Mingyi Chen, Mina L. Xu, Zenggang Pan	7
14	Isolated anemia in patients with large granular lymphocytic leukemia (LGLL) 2022 ·Blood Cancer Journal ·(unknown), Fang Zhao, Jennifer L. Oliveira, Yuan Ji, Dragan Jevremović, Ronald S. Go, Wei Ding, Sameer A. Parikh, Mithun Vinod Shah, Paul J. Hampel, Aref Al‐Kali, William G. Morice, Min Shi	6
15	Aberrant expression of lymphoid enhancer–binding factor 1 in Hodgkin lymphoma 2022 ·Human Pathology ·Aishwarya Ravindran, Paul J. Kurtin, Rebecca L. King, Yuan Ji, Andrew L. Feldman, Karen L. Rech, Ellen D. McPhail, Sameer A. Parikh, Wei Ding, Min Shi	2
16	Improved Characterization of Complex β-Globin Gene Cluster Structural Variants Using Long-Read Sequencing 2021 ·Journal of Molecular Diagnostics ·(unknown), (unknown), Garrett Jenkinson, (unknown), Ross A. Aleff, Christopher A. Hilker, Joseph H. Blommel, (unknown), (unknown), Patrick A. Lundquist, (unknown), Min Shi, Rong He, David S. Viswanatha, Jin Jen, Eric W. Klee, Benjamin R. Kipp, James D. Hoyer, Eric D. Wieben, Jennifer L. Oliveira	10
17	Utility of TRBC1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lymphoma 2020 ·Journal of Investigative Dermatology ·Pedro Horna, Min Shi, Dragan Jevremović, Fiona E. Craig, Nneka I. Comfere, Horatiu Olteanu	26
18	Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma 2019 ·Blood Cancer Journal ·James B. Smadbeck, Jess F. Peterson, Kathryn E. Pearce, Beth A. Pitel, (unknown), Michael Timm, Dragan Jevremović, Min Shi, A. Keith Stewart, Esteban Braggio, Daniel L. Riggs, P. Leif Bergsagel, George Vasmatzis, Hutton M. Kearney, Nicole L. Hoppman, Rhett P. Ketterling, Shaji Kumar, S. Vincent Rajkumar, Patricia T. Greipp, Linda B. Baughn	29
19	Iron Dinitrogen Complexes Supported by Tris(NHC)borate Ligand: Synthesis, Characterization, and Reactivity Study 2018 ·Acta Chimica Sinica ·(unknown), Jun Cheng, Yafei Gao, Min Shi, Liang Deng	20
20	T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas 2017 ·American Journal of Clinical Pathology ·Tanu Goyal, Beenu Thakral, Sa A. Wang, Carlos E. Bueso‐Ramos, Min Shi, Dragan Jevremović, William G. Morice, (unknown), Tracy I. George, (unknown), Siddharth Bhattacharyya, Adam Bagg, Heesun J. Rogers, Juraj Bodo, Lisa Durkin, Eric D. Hsi	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact